Trial Profile
A Phase II Study Of Epothilone B Analogue BMS-247550 (NSC 710428) q21 Days In Advanced Carcinoma Of The Urothelium
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Jan 2013
Price :
$35
*
At a glance
- Drugs Ixabepilone (Primary)
- Indications Urogenital cancer
- Focus Therapeutic Use
- 05 Nov 2007 Status changed from in progress to completed.
- 19 Sep 2005 New trial record.